1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
49 
Sec. 203. The Commission shall undertake a compre- 
hensive study of the ethical, social, and legal implications of 
advances in recombinant DXA activities. Such stud} 7 shall 
include — 
(1) an analysis and evaluation of scientific and 
technological advances in past, present, and projected 
recombinant DXA activities; 
(2-) an analysis and evaluation of the implications 
of such advances, both for individuals and for society; 
(3) an analysis and evaluation of the laws and 
moral and ethical principles governing the use of recom- 
binant DXA technology in medical practice and other 
fields ; 
(4) an analysis and evaluation of public under- 
standing and attitudes toward such implications and laws 
and principles ; 
(5) an analysis and evaluation of the implications 
for public policy of such findings as are made by the 
Commission with respect to advances in recombinant 
DXA research and technology and the public attitude 
toward such advances; and 
(6) an analysis and evaluation of the implications 
of recombinant DXA activities within the field of 
genetic engineering. 
8lX'. 2o4. (a) - The ( 'i>iiimi.->ion shall in carrying out 
[ 668 ] 
